TITLE:
Linking ADHD Treatment to Lifespan Brain Health: Evaluating Combined Stimulant and Cognitive-Behavioral Interventions in Dementia Risk
AUTHORS:
Muping Yu, William Reuther
KEYWORDS:
ADHD, Brain Health, Childhood, Dementia Risk, Cognitive Behavioral Therapy
JOURNAL NAME:
Open Journal of Modern Neurosurgery,
Vol.16 No.2,
March
27,
2026
ABSTRACT: This narrative review examines evidence linking Attention-Deficit/Hyperactivity Disorder (ADHD) and long-term brain health, with a focus on how stimulant medication and cognitive-behavioral therapy (CBT) may influence cognitive aging. ADHD involves dysregulated dopamine signaling that impairs reward processing and executive control, contributing to lifelong cognitive and behavioral challenges. Large epidemiological studies indicate that adults with ADHD have a higher incidence of mild cognitive impairment (MCI) and dementia, even after accounting for psychiatric comorbidities. However, individuals treated with stimulant medications show no such increase in dementia risk, suggesting possible neurologically protective effects. Across randomized controlled trials and meta-analyses, combined treatment with stimulant medication and CBT consistently yields greater improvements in attention, organization, and emotional regulation as compared to either approach alone. These findings support the hypothesis that multiple therapies targeting both dopamine signaling and behavioral regulation may not only optimize ADHD treatment but also reduce the likelihood of late-life cognitive decline. Integrating pharmacological and behavioral interventions may therefore represent a sustainable option for promoting cognitive health across the lifespan.